ARCHIVES

Rituximab Maintenance Improves Survival In Relapse

This article is from The Cancer Letter archive.

Vol. 32 No. 2 | February 27, 2009

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

Guideline Adherence Improves Early Breast Cancer Survival

August 27, 2004

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

Science Fellowships Available; Grants For Former Soviet Scientists

August 16, 1996